Hims & Hers Health (NYSE:HIMS) is a telehealth platform providing direct-to-consumer personal care products and virtual medical services in the United States. Operating under the Hims & Hers brand, the company offers an integrated digital experience that connects users with licensed healthcare providers, enabling online consultations and prescriptions for a range of conditions. Its telemedicine infrastructure supports both prescription medications and over-the-counter products, with home delivery to patients’ doorsteps.
The company’s product portfolio addresses key areas of men’s and women’s health, including hair loss treatments, sexual wellness therapies, skincare regimens and mental health support. Through secure online questionnaires and video visits, patients receive personalized treatment plans covering conditions such as erectile dysfunction, acne, hair thinning, anxiety and depression. Hims & Hers also distributes supplements, vitamin formulations and topical solutions designed to complement its prescription offerings.
Founded in 2017 by Andrew Dudum and headquartered in San Francisco, Hims & Hers emerged as one of the first telehealth subscriptions focused on consumer-friendly branding and straightforward access to care. In July 2021, the company completed a business combination with a special purpose acquisition company, enabling its public listing on the New York Stock Exchange under the ticker HIMS. Since its inception, Hims & Hers has pursued strategic partnerships and acquisitions to expand its medical and technological capabilities.
Serving customers across the continental U.S., Hims & Hers continues to develop its digital care model by enhancing telehealth platform features, broadening its therapeutic categories and strengthening clinical support. Under the leadership of CEO Andrew Dudum and a team of healthcare and technology executives, the company aims to reduce barriers to medical access while driving scalable growth in the evolving virtual care market.
